Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 8/20 | 0.35 |
| ▸ | SLC5A1 | P13866 | 4/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.32 |
| ▸ | MAP1LC3B | Q9GZQ8 | 1/20 | 0.32 |
| ▸ | MAP1LC3A | Q9H492 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953414 | 1.00 | IGF1R (0.38) | IGF1RSCN9ASLC5A1EGFRAAK1 | |
| SCHEMBL30953308 | 0.86 | IL17A (0.33) | SLC5A1 | |
| Hydrochloric Acid SCHEMBL30953395 | 0.85 | SLC5A1 (0.33) | IGF1RSLC5A1 | |
| SCHEMBL30953106 | 0.85 | IL17A (0.39) | SLC5A1 | |
| SCHEMBL30953034 | 0.85 | CTSL (0.40) | CTSS | |
| SCHEMBL30953040 | 0.83 | IL17A (0.47) | — | |
| SCHEMBL30952986 | 0.83 | IGF1R (0.39) | IGF1RSCN9AEGFRAAK1CYP3A4 | |
| SCHEMBL30953436 | 0.83 | ABCB11 (0.36) | SCN9ASLC5A1EGFRAAK1CYP3A4 | |
| SCHEMBL30953525 | 0.83 | ABCB11 (0.36) | SCN9ASLC5A1EGFRAAK1CYP3A4 | |
| SCHEMBL30952956 | 0.82 | AAK1 (0.40) | IGF1RSCN9AAAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |